NDA median approval time is shortened by 7% to 15.4 months in 1996.
FDA 1996 MEDIAN NDA APPROVAL TIME OF 15.4 MONTHS IS 7% FASTER than the 1995 median time of 16.5 months, according to an analysis of 1996 review data released by FDA on Jan. 14. FDA approved 131 NDAs in 1996, a 60% increase over 1995's 82 NDAs. With eight biological approvals bringing the total number of new products approved to 139, FDA approved 63% more drugs and biologicals in 1996 than in 1995, when 85 new products were approved.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth